Mirella Biava
Medical scientific liaison at Angelini- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Inglese Native or bilingual proficiency
-
Francese Native or bilingual proficiency
-
Spagnolo Elementary proficiency
Topline Score
Bio
Experience
-
Angelini Holding
-
Italy
-
Manufacturing
-
1 - 100 Employee
-
Medical scientific liaison
-
May 2017 - Present
-
-
-
IRCCS Instituto Nazionale Malattie Infettive "L. Spallanzani"
-
Hospitals and Health Care
-
100 - 200 Employee
-
biology
-
Mar 2015 - May 2017
-
-
biologa
-
Jan 2015 - May 2017
▪ Research activities in the framework of the USA – FDA funded project “Field validation of a BSL-2 assay to diagnose total and neutralizaing anti-Ebola antibodies in West Africa”: implementation of a new and stable laboratory in Freetown, Sierra Leone; neutralization tests and ELISA with the tests developed in USA by Dr Kaplan; transfer of the technology to Freetown, Sierra Leone.▪ Research activities in the frame work of the European Project Horizon 2020 – EVIDENT on emergin viruses. In particular, research activities on filoviruses to forefront the Ebola outbreak in West Africa: differential diagnosis, relevance of the presence of co-infections; sequencing activities; gene expression analysis on chemokines and cytokines.
-
-
biology
-
Apr 2016 - Jun 2016
▪ Research activities in the frame work of the European Projects IMI – FILODIAG, MOFINA and MODRAD;Horizon 2020 EVIDENT; USA - FDA “ Field validation of a BSL-2 assay to diagnose total and neutralizing antibodies in West Africa”: database analysis and selection of samples; differential diagnosis; evaluation of the presence of co-infections in patients with Ebola Virus Disease; field sequencing (MinION, Oxford Nanopore); preliminary tests with new qRT-PCR and lateral flow prototypes for EVD diagnosis. Implementation of a new and stable laboratori in the Princess Christian Maternity Hospital, Freetown, Sierra Leone for the diagnosis of viral hemorrhagic fevers. Diagnostic activities in the framework of the “Ebola Virus Disease Surveillance program”.
-
-
-
Duke University Medical Center
-
Hospitals and Health Care
-
700 & Above Employee
-
Research Scholar
-
Oct 2013 - Aug 2014
-
-
-
-
Laurea Specialistica in Biotecnologie Mediche
-
2013 - 2014
-
-
Education
-
Sapienza Università di Roma
Scuola di Specializzazione, microbiologia e virologia -
Sapienza Università di Roma
Scuola di Specializzazione, Virologia e Microbiologia -
Sapienza Università di Roma
Scuola di Specializzazione, Microbiologia e Virologia -
Sapienza Università di Roma
Master's degree, biotecnologie mediche